Scrip's five biggest clinical setbacks of 2014, so far�
This article was originally published in Scrip
Executive Summary
The close of 2014 is fast approaching, and as the door closes on tax inversion deals, Scrip has taken a look at another area of disappointment for companies so far this year: major clinical trial failures.